TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Vimian Group AB ( (SE:VIMIAN) ) is now available.
Vimian Group AB has announced the appointment of its Nomination Committee for the 2026 Annual General Meeting, based on the ownership structure as of August 31, 2025. This development is crucial for stakeholders as it sets the stage for the upcoming AGM scheduled for April 29, 2026, where shareholders can influence the company’s strategic direction by submitting proposals to the committee.
The most recent analyst rating on (SE:VIMIAN) stock is a Hold with a SEK37.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company specializing in Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Headquartered in Stockholm, Sweden, it serves over 17,000 veterinary clinics and laboratories across more than 80 markets, employing 1,200 people with annual revenues of approximately EUR 375 million.
Average Trading Volume: 693,104
Technical Sentiment Signal: Sell
Current Market Cap: SEK15.94B
See more insights into VIMIAN stock on TipRanks’ Stock Analysis page.